DUAL-HVP
Psychosocial Protective Factors and Clinical-Functional Outcomes in Hospitalized Patients With Dual Diagnosis: An Observational, Cross-Sectional, Single-Center Study
Sponsor study identifier
observational
125
1 country
1
Study Start
March 1, 2026
Actual (reported)Primary Completion
April 30, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
April 30, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Dual diagnosis, defined as the co-occurrence of a mental disorder and a substance use disorder, is frequently associated with increased clinical severity, functional impairment, and poorer health outcomes. Identifying psychosocial protective factors related to better clinical and functional outcomes is essential to improve patient care and treatment planning. The aim of this observational, cross-sectional, single-center study is to analyze psychosocial protective factors and their association with clinical-functional outcomes in hospitalized patients with dual diagnosis. The study will be conducted in a general hospital setting and will include adult inpatients diagnosed with dual diagnosis according to clinical criteria. Sociodemographic, clinical, and psychosocial variables will be collected using standardized assessment tools and clinical records. The results of this study are expected to contribute to a better understanding of psychosocial factors associated with clinical severity and functional outcomes in patients with dual diagnosis, supporting more comprehensive and patient-centered care approaches.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 30, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 18, 2026
Actual (reported)March 1, 2026
Actual (reported)March 2, 2026
Actual (reported)April 30, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
April 30, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Medication adherence measured by Simplified Medication Adherence Questionnaire (SMAQ)
Medication adherence assessed using the 6-item Simplified Medication Adherence Questionnaire (SMAQ). Participants will be classified as adherent or non-adherent according to the original scoring criteria.
Baseline (within 72 hours of hospital admission)
Observed treatment adherence during hospitalization (clinical proxy index 0-3)
At hospital discharge (average length of stay approximately 10-14 days)
Clinical severity measured by Clinical Global Impression - Severity scale (CGI-S)
Baseline (within 72 hours of hospital admission)
Adult inpatients diagnosed with dual diagnosis hospitalized in a general hospital.
Adult inpatients hospitalized in a general hospital with a clinical diagnosis of dual diagnosis.
Hospital Virgen del Puerto
Plasencia, Caceres, 10600, Spain
María Josefa Lorenzo Bragado, MD
Hospital Virgen del Puerto
First Submitted
February 18, 2026
First Posted
March 2, 2026
Study Start
March 1, 2026
Actual (reported)Primary Completion
April 30, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
VR as a Facilitator for Participation in Society Among Persons With MHD/SUD
Health-related quality of life measured by EuroQol-5D-5L index score
Baseline (within 72 hours of hospital admission)
Self-rated health status measured by EQ-5D Visual Analog Scale (VAS)
Baseline (within 72 hours of hospital admission)
Suicidal ideation measured by Columbia-Suicide Severity Rating Scale (C-SSRS)
Baseline (within 72 hours of hospital admission)
Contact the study team to confirm eligibility.
Study Completion
April 30, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
October 7, 2026
Record last verified: 2026-10
Individual participant data will not be shared to protect participant confidentiality and in accordance with local ethics committee approval and institutional data protection regulations.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: